Results

Total Results: 1,643 records

Showing results for "factor".

1. Recombinant-Factor-Viia Clinician (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/pdf/recombinant-factor-viia_clinician.pdf
   October 01, 2010 - Vessel Conditions Off-Label Uses of rFVIIa Key Clinical Issue Off-label use of recombinant activated factor … of bleeding in patients with hemophilia A or B with inhibitors, acquired hemophilia, or congenital factor … Utilization and Clinical Data on In-Hospital, Off-Label Uses of Recombinant Factor VIIa 1 In January … information in this guide is based on Comparative Effectiveness of In-Hospital Use of Recombinant Factor

2. Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/research

3. Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor VIIa | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/clinician

4. Effectiveness and Off-Label Use of Recombinant Factor VIIa | Effective Health Care (EHC) Program
   effectivehealthcare.ahrq.gov/products/recombinant-factor-viia/slides

5. Dental Care for People With Hemophilia: A Rapid Response Literature Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/hemophilia-dental-rapid-response.pdf
   July 01, 2024 - "[ot] OR "Factor IX Deficiency"[ot] OR "Christmas Disease"[ot] OR "factor viii deficiency"[ot] OR "factor … 8' OR 'antih*emophilic factor' OR 'antih*emophilic globulin' OR 'factor viii' OR 'factor ix' OR 'factor … ix' OR 'factor xi' OR 'plasma thromboplastin component' OR 'factor 8' OR 'factor 9' OR f9 OR 'factor … factor VIII by 2%. … “Antihemophilic factor is not the only answer for all factor VIII deficiencies.”

6. Refining Key Questions: Interactive Case Study Quiz
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/rfviia.pptx
   May 01, 2010 - Introduction to Recombinant Activated Factor VII (rFVIIa) Yank V, et al. … Introduction to Recombinant Activated Factor VII (rFVIIa) Recombinant activated factor VII (rFVIIa) … X activation, even in the absence of tissue factor. … Recombinant factor VIIa for warfarin-associated intracranial bleeding. … Activated recombinant factor VII in orthotopic liver transplantation.

7. Refining Key Questions: Interactive Case Study Quiz
   effectivehealthcare.ahrq.gov/sites/default/files/rfviia.pptx
   May 01, 2010 - Introduction to Recombinant Activated Factor VII (rFVIIa) Yank V, et al. … Introduction to Recombinant Activated Factor VII (rFVIIa) Recombinant activated factor VII (rFVIIa) … X activation, even in the absence of tissue factor. … Recombinant factor VIIa for warfarin-associated intracranial bleeding. … Activated recombinant factor VII in orthotopic liver transplantation.

8. Layout 1 (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
   May 01, 2010 - currently available to support the effectiveness and safety of using recombinant activated coagulation factor … uses in hemophilia patients who have developed antibody inhibitors that compromise the use of standard factor … Comparative Effectiveness of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications vs … rFVIIa is a form of human factor VII produced by recombinant technology. … VIII or factor IX, respectively.

9. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
   March 01, 2024 - RR = 0.98; CI: 0.06, 15.05 Neurosensory alteration: 0/40, 1/39 RR = 0.33; CI: 0.01, 7.95 Risk factor … units Titer: high titer Timing: 9 days Control: Placebo Cutoff: 45 days or less: 28 Risk factor … Analysis Risk of Bias (ROB) RR = 2.96; CI: 0.12, 72.49 Risk factor analysis: NR Pub … Analysis Risk of Bias (ROB) RR = 3.03; CI: 0.12, 74.27 Risk factor analysis: NR Pub … Analysis Risk of Bias (ROB) RR = 3.02; CI: 0.12, 73.90 Risk factor analysis: NR Pub

10. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_disposition-comments.pdf
    June 01, 2010 - Comparative Effectiveness of Recombinant Factor VIIa for Off-Label Indications vs. Usual Care. … Thromboembolic adverse events after use of recombinant human coagulation factor VIIa. … Treatment of traumatic bleeding with recombinant factor VIIa. … Recombinant activated coagulation factor VII and bleeding trauma patients. … " or "Factor IX" or "Factor VIII" as if they were proper nouns, which they are not.

11. Effective Health Care (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0068_01-30-2009.pdf
    January 01, 2009 - Results of Topic Selection Process & Next Steps  Antinuclear autoantibody and rheumatoid factor … The nominator is interested in the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor … 3. a) What is the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor (RF) for children … vague musculoskeletal complaints  Age  Race/ethnicity Antinuclear Autoantibody and Rheumatoid Factor

12. Community Forum Deliberative Methods Demonstration: Evaluating Effectiveness and Eliciting Public Views on Use of Evidence--Executive Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/deliberative-methods-demonstration-executive-131125.pdf
    November 01, 2013 - • Evidence of physical harm was the most persuasive factor in accepting boundaries. … • Evidence of economic harm was also a persuasive factor in restricting choice. … Ratings for the factor assessing facilitator neutrality were fairly high. … For the quality of communication and discourse, CD reported higher scores for the factor respect for … For the implementation process, CD reported higher scores for the factor implementation quality.

13. MEDLINE Searches (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - Single risk factor only 102. Dignam JJ, Fisher B. … Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, … Single risk factor only 230. Potter CE, Beldock JG. … Single risk factor only 237. Rhodes DJ. … Single risk factor only 273. Swerdlow AJ, Jones ME.

14. CER 217 Management of Infertility Evidence Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - The most common demographic factor associated with female infertility is “advanced reproductive age … 6 PCOS Endometriosis Unexplained Infertility Tubal or Peritoneal Factor KQ 1 KQ 2 KQ 3 KQ 4 … addressed outcomes after treatment for tubal or peritoneal factor infertility. … infertility (KQ 4); and male factor infertility (KQ 5). … Tubal factor infertility and perinatal risk after assisted reproductive technology.

15. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
    December 01, 2023 - • Limited depth and quality of available research within each risk factor domain— including racism … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … Limited depth and quality of available research within each risk factor impeded our ability to outline

16. Transparency of Reporting Requirements: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - for different etiologies (i.e., KQ 1, polycystic ovarian syndrome; KQ 2, endometriosis; KQ 4, tubal factor … body mass index (BMI), presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … : o ICSI (note that interventions and comparators may vary depending on underlying cause of male factor

17. Musculoskeletal-Complaints-Tests-Children Surveillance (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … .................................................... 5 1 Antinuclear Antibody, Rheumatoid Factor … Introduction Comparative Effectiveness Review (CER) #50, Antinuclear Antibody, Rheumatoid Factor … we had also identified in our electronic search.7 That study reported the prevalence of Rheumatoid Factor … / or (rheumatoid adj factor*).ti,ab. 4 limit 3 to (english language and yr="2009 - 2013") 5 2 or

18. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - Because of their decreased binding to platelet factor 4, LMWHs have a lower incidence of thrombocytopenia … Rivaroxaban is an oral factor Xa inhibitor that was approved by the FDA in July 2011 for VTE prophylaxis … Trauma is known to be a major risk factor for VTE. …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and

19. Untitled (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
    October 12, 2015 - • Male)Factor KQ#5 KQ#6 ! … factor!infertility,!other!female!causes!of!infertility,!or! common!comorbidities!such!as! … factor!infertility,!presence!of! endometrioma,!other!female!causes!of!infertility,!or! common! … factor!infertility),!testicular!sperm!extraction,! vasectomy!reversal,!surgical!repair!of! … Tubal factor infertility and perinatal risk after assisted reproductive technology.

20. CER 217 Disposition of Comments: Management of Infertility (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - Some of these concepts I am trying to bring out (IE ICIS works for male factor infertility) can be … IE start with ICIS works for male factor in the introduction and then state looking at subgroups IE … (Page 12, line 24) We have clarified that this is the most common demographic factor, not the most … We agree that the evidence supporting male factor infertility treatments is sparse. … We agree that the evidence supporting male factor infertility treatments is sparse.